Villere ST Denis J & Co. LLC Trims Position in Option Care Health, Inc. $OPCH

Villere ST Denis J & Co. LLC decreased its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 2.8% during the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 881,383 shares of the company’s stock after selling 25,375 shares during the period. Option Care Health accounts for approximately 2.8% of Villere ST Denis J & Co. LLC’s portfolio, making the stock its 14th largest holding. Villere ST Denis J & Co. LLC owned approximately 0.54% of Option Care Health worth $28,627,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of OPCH. USA Financial Formulas purchased a new position in shares of Option Care Health during the second quarter valued at approximately $26,000. Northwestern Mutual Wealth Management Co. increased its position in Option Care Health by 1,492.9% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company’s stock worth $31,000 after purchasing an additional 836 shares during the last quarter. Brooklyn Investment Group increased its position in Option Care Health by 186.6% during the first quarter. Brooklyn Investment Group now owns 1,198 shares of the company’s stock worth $42,000 after purchasing an additional 780 shares during the last quarter. Bessemer Group Inc. increased its position in Option Care Health by 62.3% during the first quarter. Bessemer Group Inc. now owns 1,560 shares of the company’s stock worth $54,000 after purchasing an additional 599 shares during the last quarter. Finally, Wealthquest Corp acquired a new position in Option Care Health during the first quarter worth approximately $66,000. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on OPCH shares. Citigroup reaffirmed an “outperform” rating on shares of Option Care Health in a research report on Thursday, July 31st. Barrington Research reaffirmed an “outperform” rating and set a $38.00 price target on shares of Option Care Health in a research report on Tuesday, September 23rd. JMP Securities upped their price target on shares of Option Care Health from $36.00 to $38.00 and gave the stock a “market outperform” rating in a research report on Thursday, July 31st. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Option Care Health in a research report on Wednesday. Finally, TD Cowen assumed coverage on shares of Option Care Health in a research report on Thursday, October 2nd. They set a “hold” rating and a $30.00 price target for the company. Eight equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, Option Care Health has an average rating of “Moderate Buy” and an average price target of $35.11.

Insider Activity at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 36,000 shares of the stock in a transaction that occurred on Wednesday, August 20th. The stock was acquired at an average cost of $27.15 per share, with a total value of $977,400.00. Following the acquisition, the director owned 375,390 shares in the company, valued at approximately $10,191,838.50. This trade represents a 10.61% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Norman L. Wright purchased 3,411 shares of the stock in a transaction that occurred on Tuesday, September 9th. The shares were purchased at an average cost of $29.31 per share, with a total value of $99,976.41. Following the completion of the acquisition, the director owned 15,501 shares in the company, valued at approximately $454,334.31. This represents a 28.21% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders bought 59,411 shares of company stock valued at $1,627,576. Corporate insiders own 0.64% of the company’s stock.

Option Care Health Price Performance

Option Care Health stock opened at $26.71 on Friday. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53. The firm has a fifty day moving average of $28.10 and a 200-day moving average of $30.57. The firm has a market capitalization of $4.33 billion, a P/E ratio of 21.37, a PEG ratio of 1.63 and a beta of 0.88. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.01. The business had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.35 billion. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The business’s revenue was up 15.4% on a year-over-year basis. During the same period last year, the business earned $0.30 EPS. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.